18F-Fluciclovine Imaging Differentiates Progression From Treatment-Related Changes in Brain Metastases

18F-Fluciclovine Imaging Differentiates Progression From Treatment-Related Changes in Brain Metastases

18F-Fluciclovine (Axumin) PET/MRI accurately detected disease progression and tumor prolapse in brain metastases in patients with solid tumors and ruled out disease in non-progressors, according to findings from an ongoing study of the…

Continue Reading